Spinal Muscular Atrophy (SMA) - Epidemiology Insights to 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 40
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Spinal Muscular Atrophy (SMA) -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Spinal Muscular Atrophy (SMA) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Spinal Muscular Atrophy (SMA). The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Spinal Muscular Atrophy (SMA). The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

  • The Report includes the prevalent population and how will it change over the next eight years.

  • Coverage of key Spinal Muscular Atrophy (SMA) sub-populations and its prevalent or incident cases

  • Prevalent or incident cases segmented by age and sex.

  • The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

  • Developing business strategies by understanding the trends shaping and driving the global Spinal Muscular Atrophy (SMA) market.

  • Identifying prevalent patient populations as well as risk factors in the global Spinal Muscular Atrophy (SMA) market will help to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Spinal Muscular Atrophy (SMA) therapeutics in each of the markets covered.

Spinal Muscular Atrophy (SMA) - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary
Key Findings

4. Spinal Muscular Atrophy (SMA) Overview
Spinal Muscular Atrophy (SMA) Definition
Pathophysiology
Symptoms
Etiology

5. Risk Factors Associated with Spinal Muscular Atrophy (SMA)

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Spinal Muscular Atrophy (SMA)
Sex-Specific Prevalent/Incident Cases of Spinal Muscular Atrophy (SMA)
Disease Type Specific Prevalent/Incident Cases of Spinal Muscular Atrophy (SMA)

8.Prevalent & Incident Cases by 7 MM-2015-2025
Spinal Muscular Atrophy (SMA) Epidemiology of United States-2025
Spinal Muscular Atrophy (SMA) Epidemiology of United Kingdom-2025
Spinal Muscular Atrophy (SMA) Epidemiology of Germany-2025
Spinal Muscular Atrophy (SMA) Epidemiology of France-2025
Spinal Muscular Atrophy (SMA) Epidemiology of Spain-2025
Spinal Muscular Atrophy (SMA) Epidemiology of Italy-2025
Spinal Muscular Atrophy (SMA) Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

11.Report Methodology

12. Consulting Services

13. Disclaimer

14. About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Spinal Muscular Atrophy (SMA) Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Spinal Muscular Atrophy (SMA) Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Spinal Muscular Atrophy (SMA) (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Spinal Muscular Atrophy (SMA) By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Spinal Muscular Atrophy (SMA) Sub-population,Japan (2015-2025)
  • United States Virus Like Particles Market Report 2017
    Published: 12-Oct-2017        Price: US 3800 Onwards        Pages: 107
    In this report, the United States Virus Like Particles market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rat......
  • Global Virus Like Particles Sales Market Report 2017
    Published: 10-Oct-2017        Price: US 4000 Onwards        Pages: 118
    In this report, the global Virus Like Particles market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Virus Like Particles for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Ja......
  • Heavy Metal Poisoning - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 40
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Heavy Metal Poisoning - Pipeline Review, H2 2017, provides an overview of the Heavy Metal Poisoning (Toxicology) pipeline landscape.Heavy metal poisoning is the accumulation of heavy metals, in toxic amounts, in the soft tissues of the body. Sources of toxicity can include environmental, water supply, industrial and hobbies. Symptoms include headaches, drowsiness, confusion, seizures, nausea, vomiting, abdomin......
  • Radiation Injury - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 46
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiation Injury - Pipeline Review, H2 2017, provides an overview of the Radiation Injury (Toxicology) pipeline landscape.Radiation injury is damage to tissues caused by exposure to ionizing radiation. Symptoms depend on whether radiation exposure involves the whole body or is limited to a small portion of the body. At high doses, whole-body exposure causes acute radiation illness, and partial-body exposure ca......
  • Low Back Pain - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 98
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Low Back Pain - Pipeline Review, H2 2017, provides an overview of the Low Back Pain (Central Nervous System) pipeline landscape.Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, or injury, aging, arthritis, illness and cancer involving the spine. Symptoms include tingling or burning sensation, a dull achy feeling, or sharp pain and weakness in......
  • Binge Eating Disorder - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 62
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Binge Eating Disorder - Pipeline Review, H2 2017, provides an overview of the Binge Eating Disorder (Central Nervous System) pipeline landscape.Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase your risk. Signs ......
  • Global Microbiome Therapeutics Market Research Report 2017
    Published: 10-Oct-2017        Price: US 2900 Onwards        Pages: 127
    In this report, the global Microbiome Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Microbiome Therapeutics in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - Ch......
  • Global Sexual Dysfunction Partnering 2010 to 2017
    Published: 01-Oct-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Sexual Dysfunction Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology type The report provides ......
  • Global Musculoskeletal Partnering 2010-2017: Deal trends, players and financials
    Published: 01-Oct-2017        Price: US 2995 Onwards        Pages: 1000
    "Delivery of this report will take 1-3 days after purchase." Global Musculoskeletal Partnering 2010 to 2017 provides the full collection of Musculoskeletal disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Musculoskeletal partnering deals Financial deal terms for headline, upfront and royalty by stage of development Musculoskeletal partnering agreement structure Musculoskel......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs